Product Code: GVR-3-68038-060-6
Veterinary Pain Management Market Growth & Trends:
The global veterinary pain management market size is expected to reach USD 3.20 billion by 2030, registering a CAGR of 6.46% from 2024 to 2030, according to a new report by Grand View Research, Inc. The primary drivers of market growth include the advent of monoclonal antibodies in OA associated pain control, rising prevalence of diseases in animals such as osteoarthritis, rising pet ownership, increasing number of veterinarians, and increasing animal health expenditure. In May 2023, Zoetis's Librela mAb received the U.S. FDA approval for use in dog OA pain control. Moreover, pet insurance adoption is increasing due to a number of factors, including pet humanization, a growing pet population, greater initiatives by major companies, and rising veterinary care expenses.
Increasing number of veterinarians is expected to fuel the market growth. For instance, according to AVMA, there were a total of 127,131 vet practitioners in the U.S. veterinarians are now better equipped with tools and knowledge to identify and address pain in animals, whether it's acute or chronic. Moreover, there's a greater emphasis on educating veterinarians about recognizing and managing pain in animals. Veterinary schools are incorporating pain management into their curricula, and continuing education programs keep practicing veterinarians up-to-date on the latest techniques and medications. Overall, the increasing number of veterinarians driving the veterinary pain management market reflects a positive shift towards better care and understanding of animals' needs, aligning with the broader trend of humanizing pets and recognizing their emotional and physical well-being.
Veterinary pain management has become a crucial aspect of pet care, particularly with conditions such as cancer, where pain can be a significant symptom. With the increase in cancer cases among dogs, there's likely a corresponding increase in the demand for effective pain management solutions in veterinary practice. Approximately fifty percent of dogs over the age of ten develop cancer. Cancer in dogs occurs at a rate similar to that of humans. There are certain cancers that affect cats more frequently than dogs, like lymphoma. In order to help manage pain in dogs with cancer, veterinarians frequently combine pharmaceuticals, such as analgesics and anti-inflammatory medicines, with complementary therapies, such as acupuncture and physical therapy.
Furthermore, ke, and acquisitions, regional expansions, etc., such as product launches, mergers and acquisitions, regional expansions, etc., to increase their foothold in the market. For instance, in January 2024, Ceva acquired Scout Bio, a leading biotechnology firm specializing in advanced therapies for pets. This acquisition marks a substantial advancement for Ceva, granting access to groundbreaking treatments such as monoclonal antibodies and gene therapy aimed to tackle chronic pet diseases.
Veterinary Pain Management Market Report Highlights:
- Based on animal type, the production animals segment accounted for the largest market share in terms of revenue in 2023, owing to the rising prevalence of chronic illnesses, greater awareness among animal health organizations, and substantial costs associated with animal healthcare in emerging economies.
- Based on product, Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment accounted for the largest market share in terms of revenue in 2023.
- Based on indication, the osteoarthritis (OA) segment held largest market share in terms of revenue in 2023, owing to high prevalence of the disease; especially in canine animals.
- Based on end-use, hospitals & clinics segment dominated the veterinary pain management market with a share of over 82.71% in 2023.
- Based on mode of purchase, the prescription segment dominated the veterinary pain management market in 2023.
- Based on route of administration, the oral segment dominated the veterinary pain management market in 2023. Oral tablets are easier to administer compared to other forms of medication like injections.
- In 2023, North America accounted for the largest share of 38.26% in the veterinary pain management market.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources
- 1.3.4. Primary Research
- 1.4. Information/Data Analysis
- 1.5. Market Formulation & Visualization
- 1.6. Data Validation & Publishing
- 1.7. Model Details
- 1.7.1. Commodity flow analysis
- 1.7.2. Global Market: CAGR Calculation
- 1.8. List of Secondary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. Veterinary Pain Management Market Variable Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market
- 3.1.2. Ancillary Market
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Pet Ownership
- 3.2.1.2. Rising Number Of Pet Owners & Veterinary Practitioners
- 3.2.1.3. Increasing Animal Health Expenditure
- 3.2.1.4. Increasing Incidence Of Pet Obesity
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High pet care cost
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Market Challenge Analysis
- 3.3. Veterinary Pain Management Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Bargaining power of suppliers
- 3.3.1.2. Bargaining power of buyers
- 3.3.1.3. Threat of substitution
- 3.3.1.4. Threat of new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political & Legal landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.3. Regulatory Framework
- 3.3.4. Pricing Analysis
- 3.3.5. Estimated Animal Population, by key countries & Key species, 2023
- 3.3.6. COVID-19 Impact Analysis
Chapter 4. Veterinary Pain Management Market: Animal Type Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Veterinary Pain Management Market: Animal type Movement Analysis
- 4.3. Veterinary Pain Management Market Size & Trend Analysis, by animal type, 2018 to 2030 (USD Million)
- 4.4. Production Animals
- 4.4.1. Production Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5. Companion Animals
- 4.5.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 5. Veterinary Pain Management Market: By Product Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Veterinary Pain Management Market: By Product Movement Analysis
- 5.3. Veterinary Pain Management Market Size & Trend Analysis, by product, 2018 to 2030 (USD Million)
- 5.3.1. NSAIDs
- 5.3.1.1. NSAIDs Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.2. Anesthetics
- 5.3.2.1. Anesthetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.3. Opioids
- 5.3.3.1. Opioids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 5.3.4. Others
- 5.3.4.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 6. Veterinary Pain Management Market: By Indication Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Veterinary Pain Management Market: By Indication Movement Analysis
- 6.3. Veterinary Pain Management Market Size & Trend Analysis, by indication, 2018 to 2030 (USD Million)
- 6.3.1. Osteoarthritis
- 6.3.1.1. Osteoarthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. Post-operative pain
- 6.3.2.1. Post-operative pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Others
- 6.3.3.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 7. Veterinary Pain Management Market: By Route of Administration Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. Veterinary Pain Management Market: By Route of Administration Movement Analysis
- 7.3. Veterinary Pain Management Market Size & Trend Analysis, by route of administration, 2018 to 2030 (USD Million)
- 7.3.1. Parenteral
- 7.3.1.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. Oral
- 7.3.2.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Topical
- 7.3.3.1. Topical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Veterinary Pain Management Market: By Mode of Purchase Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. Veterinary Pain Management Market: By Mode of Purchase Movement Analysis
- 8.3. Veterinary Pain Management Market Size & Trend Analysis, by mode of purchase, 2018 to 2030 (USD Million)
- 8.3.1. Prescription
- 8.3.1.1. Prescription Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 8.3.2. OTC
- 8.3.2.1. OTC Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Veterinary Pain Management Market: By End-use Estimates & Trend Analysis
- 9.1. Segment Dashboard
- 9.2. Veterinary Pain Management Market: By End-use Movement Analysis
- 9.3. Veterinary Pain Management Market Size & Trend Analysis, by end-use, 2018 to 2030 (USD Million)
- 9.3.1. Hospitals & Clinics
- 9.3.1.1. Hospitals & clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 9.3.2. Others
- 9.3.2.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 10. Veterinary Pain Management Market: Regional Estimates & Trend Analysis
- 10.1. Regional Dashboard
- 10.2. Veterinary Pain Management Market Share, by region, 2023 & 2030 (USD Million)
- 10.3. Regional Outlook
- 10.4. North America
- 10.4.1. North America Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.4.2. U.S.
- 10.4.2.1. Key Country Dynamics
- 10.4.2.2. U.S. Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.4.3. Canada
- 10.4.3.1. Key Country Dynamics
- 10.4.3.2. Canada Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.4.4. Mexico
- 10.4.4.1. Key Country Dynamics
- 10.4.4.2. Mexico Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5. Europe
- 10.5.1. Europe Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.2. UK
- 10.5.2.1. Key Country Dynamics
- 10.5.2.2. UK Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.3. Germany
- 10.5.3.1. Key Country Dynamics
- 10.5.3.2. Germany Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.4. France
- 10.5.4.1. Key Country Dynamics
- 10.5.4.2. France Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.5. Italy
- 10.5.5.1. Key Country Dynamics
- 10.5.5.2. Italy Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.6. Spain
- 10.5.6.1. Key Country Dynamics
- 10.5.6.2. Spain Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.7. Denmark
- 10.5.7.1. Key Country Dynamics
- 10.5.7.2. Denmark Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.8. Sweden
- 10.5.8.1. Key Country Dynamics
- 10.5.8.2. Sweden Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.5.9. Norway
- 10.5.9.1. Key Country Dynamics
- 10.5.9.2. Norway Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6. Asia Pacific
- 10.6.1. Asia Pacific Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.2. Japan
- 10.6.2.1. Key Country Dynamics
- 10.6.2.2. Japan Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.3. China
- 10.6.3.1. Key Country Dynamics
- 10.6.3.2. China Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.4. India
- 10.6.4.1. Key Country Dynamics
- 10.6.4.2. India Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.5. Australia
- 10.6.5.1. Key Country Dynamics
- 10.6.5.2. Australia Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.6. South Korea
- 10.6.6.1. Key Country Dynamics
- 10.6.6.2. South Korea Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.6.7. Thailand
- 10.6.7.1. Key Country Dynamics
- 10.6.7.2. Thailand Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.7. Latin America
- 10.7.1. Latin America Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.7.2. Brazil
- 10.7.2.1. Key Country Dynamics
- 10.7.2.2. Brazil Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.7.3. Argentina
- 10.7.3.1. Key Country Dynamics
- 10.7.3.2. Argentina Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.8. Middle East & Africa
- 10.8.1. Middle East & Africa Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.8.2. South Africa
- 10.8.2.1. Key Country Dynamics
- 10.8.2.2. South Africa Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.8.3. Saudi Arabia
- 10.8.3.1. Key Country Dynamics
- 10.8.3.2. Saudi Arabia Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.8.4. UAE
- 10.8.4.1. Key Country Dynamics
- 10.8.4.2. UAE Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
- 10.8.5. Kuwait
- 10.8.5.1. Key Country Dynamics
- 10.8.5.2. Kuwait Veterinary Pain Management Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 11. Competitive Landscape
- 11.1. Market Participant Categorization
- 11.2. Company Market Position Analysis/ Heap Map Analysis
- 11.3. Company Profiles
- 11.3.1. Zoetis Inc.
- 11.3.1.1. Participant's Overview
- 11.3.1.2. Financial Performance
- 11.3.1.3. Product Benchmarking
- 11.3.1.4. Strategic Initiatives
- 11.3.2. VETOQUINOL.
- 11.3.2.1. Participant's Overview
- 11.3.2.2. Financial Performance
- 11.3.2.3. Product Benchmarking
- 11.3.2.4. Strategic Initiatives
- 11.3.3. BOEHRINGER INGELHEIM
- 11.3.3.1. Participant's Overview
- 11.3.3.2. Financial Performance
- 11.3.3.3. Product Benchmarking
- 11.3.3.4. Strategic Initiatives
- 11.3.4. Dechra Pharmaceuticals Plc (EQT)
- 11.3.4.1. Participant's Overview
- 11.3.4.2. Financial Performance
- 11.3.4.3. Product Benchmarking
- 11.3.4.4. Strategic Initiatives
- 11.3.5. Merck & Co., Inc.
- 11.3.5.1. Participant's Overview
- 11.3.5.2. Financial Performance
- 11.3.5.3. Product Benchmarking
- 11.3.5.4. Strategic Initiatives
- 11.3.6. CEVA ANIMAL HEALTH, LLC.
- 11.3.6.1. Participant's Overview
- 11.3.6.2. Financial Performance
- 11.3.6.3. Product Benchmarking
- 11.3.6.4. Strategic Initiatives
- 11.3.7. Norbrook
- 11.3.7.1. Participant's Overview
- 11.3.7.2. Financial Performance
- 11.3.7.3. Product Benchmarking
- 11.3.7.4. Strategic Initiatives
- 11.3.8. Chanelle Pharma (Exponent)
- 11.3.8.1. Participant's Overview
- 11.3.8.2. Financial Performance
- 11.3.8.3. Product Benchmarking
- 11.3.8.4. Strategic Initiatives
- 11.3.9. Assisi (Wind Point Partners)
- 11.3.9.1. Participant's Overview
- 11.3.9.2. Financial Performance
- 11.3.9.3. Product Benchmarking
- 11.3.9.4. Strategic Initiatives
- 11.3.10. Elanco
- 11.3.10.1. Participant's Overview
- 11.3.10.2. Financial Performance
- 11.3.10.3. Product Benchmarking
- 11.3.10.4. Strategic Initiatives
- 11.4. Strategy Mapping
- 11.4.1. Mergers & Acquisitions
- 11.4.2. Partnerships & Collaborations
- 11.4.3. Expansion
- 11.4.4. Product launch
- 11.4.5. Others
- 11.5. List of other Key players